AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
American Geriatrics Society
7 episodes
1 week ago
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
All content for AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast is the property of American Geriatrics Society and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
32 minutes
4 weeks ago
How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What Matters)
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco; Dr. Halima Amjad, Associate Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine and Dr. Lolita Nidadavolu, Assistant Professor in the Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, as they discuss How to Talk to Patients and Families About Monoclonal Antibody Treatments for Alzheimer Disease (What ...
AGS Alzheimer’s Disease: New Diagnostic Technologies and Treatments Podcast
Join Dr. Michael Harper, Professor of Medicine at the University of California, San Francisco and Dr. Daniel Parker, Associate Professor of Medicine in the Division of Geriatrics, Assistant Professor of Neurology and Medical Director at the Duke Memory Disorders Clinic at Duke University School of Medicine, as they discuss Amyloid-Targeted Therapies (ATTs) and Their Adverse Effects. To view a transcript click here then select the transcript tab.
